Rapt Therapeutics, Inc. (RAPT)
32.19
-2.54
(-7.31%)
USD |
NASDAQ |
Jan 15, 16:00
32.15
-0.04
(-0.12%)
After-Hours: 20:00
Rapt Therapeutics SG&A Expense (TTM): 29.76M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Replimune Group, Inc. | 102.36M |
| Olema Pharmaceuticals, Inc. | 18.61M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |
| Palatin Technologies, Inc. | 7.449M |
| Theriva Biologics, Inc. | 16.21M |